QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer

Clinical trial NCT07617818 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07617818
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Neoadjuvant Therapy Immunotherapy

Start date: 2026-06-15
Primary completion: 2028-06-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.